161 related articles for article (PubMed ID: 26263531)
21. Exome sequencing identifies RDH12 compound heterozygous mutations in a family with severe retinitis pigmentosa.
Chacon-Camacho OF; Jitskii S; Buentello-Volante B; Quevedo-Martinez J; Zenteno JC
Gene; 2013 Oct; 528(2):178-82. PubMed ID: 23900199
[TBL] [Abstract][Full Text] [Related]
22. Progress in histopathologic and pathogenetic research in a retinitis pigmentosa model.
Liu X; Zhang Y; He Y; Zhao J; Su G
Histol Histopathol; 2015 Jul; 30(7):771-9. PubMed ID: 25671641
[TBL] [Abstract][Full Text] [Related]
23. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
24. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
[TBL] [Abstract][Full Text] [Related]
25. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
26. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
[TBL] [Abstract][Full Text] [Related]
27. Generation of Human Patient iPSC-derived Retinal Organoids to Model Retinitis Pigmentosa.
Ma C; Jin K; Jin ZB
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786611
[TBL] [Abstract][Full Text] [Related]
28. TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa.
Bocquet B; Borday C; Erkilic N; Mamaeva D; Donval A; Masson C; Parain K; Kaminska K; Quinodoz M; Perea-Romero I; Garcia-Garcia G; Jimenez-Medina C; Boukhaddaoui H; Coget A; Leboucq N; Calzetti G; Gandolfi S; Percesepe A; Barili V; Uliana V; Delsante M; Bozzetti F; Scholl HP; Corton M; Ayuso C; Millan JM; Rivolta C; Meunier I; Perron M; Kalatzis V
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37768732
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
[TBL] [Abstract][Full Text] [Related]
30. Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling.
Bolinches-Amorós A; León M; Del Buey Furió V; Marfany G; Gonzàlez-Duarte R; Erceg S; Lukovic D
Stem Cell Res; 2019 Jul; 38():101455. PubMed ID: 31082679
[TBL] [Abstract][Full Text] [Related]
31. Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene.
Tschernutter M; Jenkins SA; Waseem NH; Saihan Z; Holder GE; Bird AC; Bhattacharya SS; Ali RR; Webster AR
Br J Ophthalmol; 2006 Jun; 90(6):718-23. PubMed ID: 16714263
[TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing reveals ZNF408 as a new gene associated with autosomal recessive retinitis pigmentosa with vitreal alterations.
Avila-Fernandez A; Perez-Carro R; Corton M; Lopez-Molina MI; Campello L; Garanto A; Fernandez-Sanchez L; Duijkers L; Lopez-Martinez MA; Riveiro-Alvarez R; Da Silva LR; Sanchez-Alcudia R; Martin-Garrido E; Reyes N; Garcia-Garcia F; Dopazo J; Garcia-Sandoval B; Collin RW; Cuenca N; Ayuso C
Hum Mol Genet; 2015 Jul; 24(14):4037-48. PubMed ID: 25882705
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profile changes caused by the dysfunction of Mer during retinal pigment epithelium phagocytosis.
Chen YY; Lu QJ; Lu QX; Wang NL
Chin Med J (Engl); 2011 Apr; 124(8):1145-55. PubMed ID: 21542987
[TBL] [Abstract][Full Text] [Related]
35. Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene.
Bai X; Chen J; Zhao X; Zhu X; Ding X; Zhang T; Jiang M; Sun X
Stem Cell Res; 2024 Jun; 77():103390. PubMed ID: 38507880
[TBL] [Abstract][Full Text] [Related]
36. [Early therapeutic trials for retinitis pigmentosa].
Dufier JL
Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of FAM46A in Spanish families with autosomal recessive retinitis pigmentosa: characterisation of novel VNTRs.
Barragán I; Borrego S; Abd El-Aziz MM; El-Ashry MF; Abu-Safieh L; Bhattacharya SS; Antiñolo G
Ann Hum Genet; 2008 Jan; 72(Pt 1):26-34. PubMed ID: 17803723
[TBL] [Abstract][Full Text] [Related]
38. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
[TBL] [Abstract][Full Text] [Related]
39. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
[TBL] [Abstract][Full Text] [Related]
40. Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosa.
Sharma TP; Wiley LA; Whitmore SS; Anfinson KR; Cranston CM; Oppedal DJ; Daggett HT; Mullins RF; Tucker BA; Stone EM
Stem Cell Res; 2017 May; 21():58-70. PubMed ID: 28390992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
